Dipeptidyl peptidase IV (CD26) activity in the hematopoietic system: Differences between the membrane-anchored and the released enzyme activity

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 5, 2003, Pages 567-578

  Pereira, D A ^a,b   Gomes, L ^b,c   El Cheikh, M C ^b   Borojevic, Radovan ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Ectoenzyme; Exopeptidase; Hematopoiesis; Membrane rafts; Stroma

Indexed keywords

ANILIDE; CHEMOKINE; CYTOKINE; DIPEPTIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV; EXOPEPTIDASE; GLYCINE; GLYCOSAMINOGLYCAN; MEMBRANE LIPID; MESSENGER RNA; POLYMER; POLYSACCHARIDE; PROLINE; PROTEIN ANTIBODY; SUGAR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE MARROW CELL; CELL ANCHORAGE; CELL INTERACTION; CELL MEMBRANE; CONNECTIVE TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME RELEASE; EXTRACELLULAR MATRIX; HEMATOPOIESIS; HEMATOPOIETIC SYSTEM; LIVER CELL; MICROENVIRONMENT; MOUSE; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; STEM CELL; STROMA CELL;

ANIMALIA; MURINAE;

EID: 0038279762     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2003000500003     Document Type: Article

References (40)

1. Hong WJ, Petell JK, Swank D, Sanford J, Hixson DC & Doyle D (1989). Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels. Experimental Cell Research, 182: 256-266.
2. Tsugiki M, Kobayashi Y, Kawasaki T & Yoshimi T (1998). Identification of bile canalicular cell surface antigen HAM.4 as dipeptidyl peptidase IV (DPPIV) and characterization of its role in hepatic regeneration after partial hepatectomy in rats. Digestive Diseases and Sciences, 43: 2591-2600.
3. Levy MT, McCoughan GW, Abbott CA, Park JE, Cunningham AM, Muller E, Rettig WJ & Gorrell MD (1999). Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology, 29: 1768-1778.
4. Hopsu-Havu VK & Glaner GG (1966). A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-β-naphthylamide. Histochimie, 7: 197-201.
5. Hegen M, Niedobitek G, Klein CE, Stein H & Fleischer B (1990). The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. Journal of Immunology, 144: 2908-2914.
6. Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF & Morimoto C (1991). Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. Journal of Immunology, 147: 2514-2517.
7. Hegen M, Kameoka J, Dong RP, Schlossman SF & Morimoto C (1997). Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology, 90: 257-264.
8. Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF & Morimoto C (1996). Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. Journal of Immunology, 156: 1349-1355.
9. Bristol LA, Sakaguchi K, Appella E, Doyle D & Takács L (1992). Thymocyte costimulating antigen is CD26 (dipeptidyl-peptidase IV): Co-stimulation of granulocyte, macrophage, and T lineage cell proliferation via CD26. Journal of Immunology, 149: 367-372.
10. Bristol LA, Bachvshin W & Takács L (1995). Inhibition of CD26 enzyme activity with Pro-boropro stimulates rat granulocyte/macrophage colony formation and thymocyte proliferation in vitro. Blood, 85: 3602-3609.
11. Scholz W, Mentlein R, Heymann E, Feller AC, Ulmer AJ & Flad H (1985). Interleukin 2 production by human T lymphocytes identified by antibodies to dipeptidyl peptidase IV. Cellular Immunology, 93: 199-211.
12. Schön E & Ansorge S (1990). Dipeptidyl peptidase IV in the immune system. Biological Chemistry Hoppe-Seyler, 371: 699-705.
13. Holst JJ & Deacon CF (1998). Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. Diabetes, 47: 1663-1670.
14. Augustyns K, Bal G, Thonus G, Belyaev A, Zhang XM, Bollaert W, Lambier AM, Durinx C, Goossens F & Haemers A (1999). The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors. Current Medicinal Chemistry, 6: 311-327.
15. Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, Nguyen NY, Boykins R, Unsworth E & Norcross MA (1997). Regulation of the receptor specificity and of the function of the chemokine RANTES by dipeptidyl peptidase IV (CD-26)-mediated cleavage. Journal of Experimental Medicine, 186: 1865-1872.
16. Van Coillie E, Proost P, Van Aelst I, Struyf S, Polfliet M, De Meester I, Harvey DJ, Van Damme J & Opendakker G (1998). Functional comparison of two human monocyte chemotatic protein-2 isoforms, roles of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry, 37: 12672-12680.
17. Lambier AM, Proost P, Durinx C, Bal G, Senten K, Augustyns K, Schrape S, Van Damme J & De Meester I (2001). Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. Journal of Biological Chemistry, 276: 29839-29845.
18. Iwaki-Egawa S, Watanabe Y & Fujimoto Y (1998). Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence. Journal of Biochemistry, 124: 428-433.
19. Loster K, Zeilinger K, Schuppan D & Reuter W (1995). The cysteinerich region of dipeptidyl peptidase IV (CD26) is the collagen-binding site. Biochemical and Biophysical Research Communications, 217: 341-348.
20. Collins LS & Dorshkind K (1987). A stromal cell line from myeloid long-term bone marrow culture can support myelopoiesis and B lymphopoiesis. Journal of Immunology, 138: 1082-1087.
21. Alvarez-Silva M & Borojevic R (1996). GM-CSF and IL-3 activities in schistosomal liver granulomas are controlled by stroma-associated heparan-sulfate proteoglycans. Journal of Leukocyte Biology, 59: 435-441.
22. Dutra HS, Rossi MID, Azevedo SP, El-Cheikh MC & Borojevic R (1997). Haematopoietic capacity of colony-forming cells mobilized into hepatic inflammatory reactions as compared to that of normal bone marrow cells. Research in Immunology, 148: 437-444.
23. Carvalho MA, Arcanjo K, Silva LCF & Borojevic R (2001). The capacity of connective tissue stromas to sustain myelopoiesis depends both upon the growth factors and the local intercellular environment. Biology of the Cell, 92: 605-614.
24. Paiva LMC, Pinto GF & Oestreicher EG (1991). Inhibition of horse liver alcohol dehydrogenase and rabbit muscle lactate dehydrogenase by phenylhydrazine. Biomedica Biochimica Acta, 50: 25-29.
25. Metzler CM (1981). Statistical properties of kinetics estimates. In: Endrenyi L (Editor), Kinetic Data Analysis: Design and Analysis of Enzyme and Pharmacokinetic Experiments. Plenum Press, New York, NY, USA, 25-37.
26. Kabouridis PS, Magee AI & Ley SC (1997). S-acylation of LCK protein tyrosine kinase is essential for its signaling function in T lymphocytes. EMBO Journal, 16: 4983-4998.
27. Alvarez-Silva M, Silva LC & Borojevic R (1993). Cell membrane-associated proteoglycans mediate extramedullar myeloid proliferation in granulomatous inflammatory reactions to schistosome eggs. Journal of Cell Science, 104: 477-484.
28. Alvarez-Silva M, Pinazo AC, El-Cheikh MC & Borojevic R (1994). Myelopoietic competence of stroma composed of hepatic granuloma-derived connective tissue cells or skin fibroblasts. Brazilian Journal of Medical and Biological Research, 27: 2143-2152.
29. Gupta P, Oegema TR, Brazil JJ, Dudek AZ, Slungaard A & Verfaillie CM (1998). Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood, 92: 4641-4651.
30. Panek AD (1995). Trehalose metabolism - new horizons in technological applications. Brazilian Journal of Medical and Biological Research, 28: 169-181.
31. Marguet D, Bernard AM, Vivier I, Darmoul D, Naquet P & Pierres M (1992). cDNA cloning for mouse thymocyte-activating molecule: A multifunctional ectodipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases. Journal of Biological Chemistry, 267: 2200-2208.
32. Bernard AM, Mattei MG, Pierres M & Marguet D (1994). Structure of the mouse dipeptidyl peptidase IV (CD26) gene. Biochemistry, 33: 15204-15214.
33. Fan H, Meng W, Kilian C, Grams S & Reutter W (1997). Domain-specific N-glycosylation of the membrane glycoprotein dipeptidyl-peptidase IV (CD26) influences its subcellular trafficking, biological stability, enzyme activity and protein folding. European Journal of Biochemistry, 246: 243-251.
34. Smith RE, Talhouk JW, Brown EE & Edgar SE (1998). The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by tat and other cationic peptides. CD26: A subverted adhesion molecule for HIV peptide binding. AIDS Research and Human Retroviruses, 14: 861-868.
35. Duke-Cohan JS, Morimoto C, Rocker JA & Schlossman SF (1995). A novel form of dipeptidylpeptidase in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidase IV (CD26). Journal of Biological Chemistry, 270: 14107-14114,
36. Kähne T, Kröning H, Thiel U, Ulmer AJ, Flad HD & Ansorge S (1996). Alteration in structure and cellular localization of molecular forms of DPP IV/CD26 during cell activation. Cellular Immunology, 170: 63-70.
37. Morimoto C & Schlossman SF (1998). The structure and function of CD26 in the T-cell immune response. Immunological Reviews, 161: 55-70.
38. Ilangumaran S, Briol A & Hoessli DC (1997). Distinct interactions among GPI-anchored, transmembrane and membrane associated intracellular proteins and sphingolipids in lymphocyte and endothelial cell plasma membranes. Biochimica et Biophysica Acta, 1328: 227-236.
39. Ait Slimane T, Lenoir C, Bello V, Delaunay JL, Goding JW, Chwetzoff S, Maurice M, Fransen JA & Trungan G (2001). The cytoplasmic/ transmembrane domain of dipeptidyl peptidase IV, a type II glycoprotein, contains an apical targeting signal that does not specifically interact with lipid rafts. Experimental Cell Research, 270: 45-55.
40. Ishii T, Ohnuma K, Murakami A, Takasawa N, Kobayashi S, Dang NH, Schlossman SF & Morimoto C (2001). CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proceedings of the National Academy of Sciences, USA, 98: